158 related articles for article (PubMed ID: 19934319)
1. Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway.
Fukushima H; Koga F; Kawakami S; Fujii Y; Yoshida S; Ratovitski E; Trink B; Kihara K
Cancer Res; 2009 Dec; 69(24):9263-70. PubMed ID: 19934319
[TBL] [Abstract][Full Text] [Related]
2. DeltaNp63alpha-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma.
Higashikawa K; Yoneda S; Tobiume K; Saitoh M; Taki M; Mitani Y; Shigeishi H; Ono S; Kamata N
Int J Cancer; 2009 Jun; 124(12):2837-44. PubMed ID: 19267405
[TBL] [Abstract][Full Text] [Related]
3. Induction of uPA gene expression by the blockage of E-cadherin via Src- and Shc-dependent Erk signaling.
Kleiner S; Faisal A; Nagamine Y
FEBS J; 2007 Jan; 274(1):227-40. PubMed ID: 17222183
[TBL] [Abstract][Full Text] [Related]
4. Expression of classic cadherins type I in urothelial neoplastic progression.
Rieger-Christ KM; Cain JW; Braasch JW; Dugan JM; Silverman ML; Bouyounes B; Libertino JA; Summerhayes IC
Hum Pathol; 2001 Jan; 32(1):18-23. PubMed ID: 11172290
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin and p63 immunoexpression in dysplastic lesions and urothelial carcinomas of the bladder.
Stepan A; Mărgăritescu C; Simionescu C; Ciurea R
Rom J Morphol Embryol; 2009; 50(3):461-5. PubMed ID: 19690775
[TBL] [Abstract][Full Text] [Related]
6. Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression.
Karni-Schmidt O; Castillo-Martin M; Shen TH; Gladoun N; Domingo-Domenech J; Sanchez-Carbayo M; Li Y; Lowe S; Prives C; Cordon-Cardo C
Am J Pathol; 2011 Mar; 178(3):1350-60. PubMed ID: 21356385
[TBL] [Abstract][Full Text] [Related]
7. Snail-induced down-regulation of DeltaNp63alpha acquires invasive phenotype of human squamous cell carcinoma.
Higashikawa K; Yoneda S; Tobiume K; Taki M; Shigeishi H; Kamata N
Cancer Res; 2007 Oct; 67(19):9207-13. PubMed ID: 17909026
[TBL] [Abstract][Full Text] [Related]
8. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
9. Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway.
Rieger-Christ KM; Lee P; Zagha R; Kosakowski M; Moinzadeh A; Stoffel J; Ben-Ze'ev A; Libertino JA; Summerhayes IC
Oncogene; 2004 Jun; 23(27):4745-53. PubMed ID: 15122336
[TBL] [Abstract][Full Text] [Related]
10. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis.
Barbieri CE; Tang LJ; Brown KA; Pietenpol JA
Cancer Res; 2006 Aug; 66(15):7589-97. PubMed ID: 16885358
[TBL] [Abstract][Full Text] [Related]
11. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder.
Koga F; Kawakami S; Fujii Y; Saito K; Ohtsuka Y; Iwai A; Ando N; Takizawa T; Kageyama Y; Kihara K
Clin Cancer Res; 2003 Nov; 9(15):5501-7. PubMed ID: 14654529
[TBL] [Abstract][Full Text] [Related]
12. α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.
Liu J; Cai M; Chen J; Liao Y; Mai S; Li Y; Huang X; Liu Y; Zhang J; Kung H; Zeng Y; Zhou F; Xie D
Eur J Cancer; 2014 Mar; 50(4):840-51. PubMed ID: 24388773
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin expression in invasive urothelial carcinoma.
Sun W; Herrera GA
Ann Diagn Pathol; 2004 Feb; 8(1):17-22. PubMed ID: 15129905
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.
Menke A; Philippi C; Vogelmann R; Seidel B; Lutz MP; Adler G; Wedlich D
Cancer Res; 2001 Apr; 61(8):3508-17. PubMed ID: 11309315
[TBL] [Abstract][Full Text] [Related]
15. Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms.
Koga F; Kawakami S; Kumagai J; Takizawa T; Ando N; Arai G; Kageyama Y; Kihara K
Br J Cancer; 2003 Mar; 88(5):740-7. PubMed ID: 12618884
[TBL] [Abstract][Full Text] [Related]
16. Loss of p63 expression is associated with tumor progression in bladder cancer.
Urist MJ; Di Como CJ; Lu ML; Charytonowicz E; Verbel D; Crum CP; Ince TA; McKeon FD; Cordon-Cardo C
Am J Pathol; 2002 Oct; 161(4):1199-206. PubMed ID: 12368193
[TBL] [Abstract][Full Text] [Related]
17. Decreased ezrin and paxillin expression in human urothelial bladder tumors correlate with tumor progression.
Athanasopoulou A; Aroukatos P; Nakas D; Repanti M; Papadaki H; Bravou V
Urol Oncol; 2013 Aug; 31(6):836-42. PubMed ID: 21868260
[TBL] [Abstract][Full Text] [Related]
18. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation.
Hulit J; Suyama K; Chung S; Keren R; Agiostratidou G; Shan W; Dong X; Williams TM; Lisanti MP; Knudsen K; Hazan RB
Cancer Res; 2007 Apr; 67(7):3106-16. PubMed ID: 17409417
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium.
Lopez-Beltran A; Alvarez-Kindelan J; Luque RJ; Blanca A; Quintero A; Montironi R; Cheng L; Gonzalez-Campora R; Requena MJ
J Pathol; 2008 Jul; 215(3):263-72. PubMed ID: 18452128
[TBL] [Abstract][Full Text] [Related]
20. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]